| ARTIVION INC. DL-,01 |
| USA |
| Gesundheit |
| US2289031005 / 900006 |
| CYL (Frankfurt) / AORT (NYSE) |
| FRA:CYL, ETR:CYL, CYL:GR, NYSE:AORT |
| - |
| https://artivion.com/ |
|
Artivion Inc. is a medical device company focused on providing innovative technology solutions aimed at improving patient outcomes. Its primary function is to develop, manufacture, and sell devices associated with cardiac and vascular surgery, with a..
>Volltext.. |
| 1482.36 Mio. EUR |
| 1646.42 Mio. EUR |
| 375.66 Mio. EUR |
| 53.2 Mio. EUR |
| 8.31 Mio. EUR |
| 0.18 EUR |
| 220.05 Mio. EUR |
| 55.25 Mio. EUR |
| 33.95 Mio. EUR |
| 0.64 |
| 0.12% |
| - |
| - |
| - |
| - |
| 09.12.15 - 0.02574€ 09.09.15 - 0.02574€ >weitere anzeigen... |
| - |
| ARTIVION |
| 08.05.26 |
|